Interperitoneal alpha-2b interferon for advanced ovarian cancer in complete remission or minimal residual disease
Cherchi, P.L.; Dessole, S.; Esposito, F.; Ambrosini, G.; El Qandil, F.Z.; Ambrosini, A.
Journal de Gynecologie Obstetrique et Biologie de la Reproduction 25(1): 101-102
1996
ISSN/ISBN: 0368-2315 PMID: 8901311 Document Number: 468038
Document emailed within 1 workday
Related Documents
Bilhou-Nabéra, C.; Marit, G.; Gharbi, M.J.; Salzes, S.; Mahon, F.X.; Broustet, A.; Reiffers, J.; Bernard, P. 1995: Chronic myelocytic leukemia patients achieving complete cytogenetic conversion under interferon alpha therapy: minimal residual disease follow-up Leukemia 9(12): 2067-2070Edmonson, J.H.; Fleming, T.R.; Decker, D.G.; Malkasian, G.D.; Jorgensen, E.O.; Jefferies, J.A.; Webb, M.J.; Kvols, L.K. 1979: Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease Cancer Treatment Reports 63(2): 241-247
Tourani, J.M.; Leaute, J.B.; Lessana-Leibowitch, M.; Andrieu, J.M. 1989: Complete remission following recombinant interferon alpha-2a in a patient with diffuse large B cell cutaneous lymphoma Nouvelle Revue Francaise d'Hematologie 31(4): 315-316
Hirano, A.; Fujita, T.; Kimura, T.; Katoh, M.; Tsuji, Y.; Kinukawa, T.; Nojiri, Y. 2006: Prolonged complete remission of multiple organ metastases after radical nephrectomy induced by interferon-alpha therapy: a case report Hinyokika Kiyo. Acta Urologica Japonica 52(12): 941-945
Casado, L.F.; Picó, M.; Gómez, C.; Ferro, M.T.; Fernández-Rañada, J.M.; Steegmann, J.L. 1997: Fluctuating molecular remission in patients with chronic myeloid leukemia with long term complete cytogenetic response after alpha interferon treatment Medicina Clinica 109(7): 251-255
Uysal, M.; Ozdogan, M.; Kargi, A.; Gunduz, S.; Sezgin Goksu, S.; Murat Tatli, A.; Arslan, D.; Mutlu, H.; Senol Coskun, H.; Bozcuk, H. 2014: Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 19(4): 980-984
Babaya, K.; Tsumatani, K.; Natsume, O.; Yoshie, T.; Kubota, K.; Ozono, S.; Hirao, Y.; Okajima, E. 1986: Complete remission obtained in advanced testicular cancer treated by etoposide (NK-171) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(3 Part 1): 604-607
Markowska, J.; Madry, R.ła.; Kierzkowski, J.; Malicki, J.; Roszak, A.; Lubin, J.; Bratos, K. 2003: Radioimmunotherapy in patients with ovarian cancer in complete remission after the first line surgery and chemotherapy after second look laparoscopy procedure Ginekologia Polska 74(9): 799-804
Mougenot, J.F.; Despert, F.; Leissler, C.; Boccon-Gibod, L.; Polonovski, C.; Combe, P. 1981: Alpha chain disease. Complete remission in one child treated at the stage of immunoblastic sarcoma Archives Francaises de Pediatrie 38(6): 431-434
Sakka, T.; Meknini, B.; Ayed, K.; Ben Jilani, S.; Ben Mami, N.; Derouiche, N. 1986: Immunoblastic sarcoma localized in the peri-pancreatic region and appearing after a complete remission of alpha chain disease La Tunisie Medicale 64(12): 1067-1070
Murgić, J.; Prpić, M.; Kirac, I.; Camino-Varela, A.-M.; Bolanca, A.; Kusić, Z. 2012: Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer Collegium Antropologicum 36(1): 325-329
Keilholz, U.; Scheibenbogen, C.; Stoelben, E.; Saeger, H.D.; Hunstein, W. 1994: Immunotherapy of metastatic melanoma with interferon-alpha and interleukin-2: pattern of progression in responders and patients with stable disease with or without resection of residual lesions European Journal of Cancer 30a(7): 955-958
Takatsuki, H.; Umemura, T.; Sadamura, S.; Yamashita, S.; Goto, T.; Abe, Y.; Yufu, Y.; Inaba, S.; Nishimura, J.; Nawata, H. 1995: Detection of minimal residual disease by reverse transcriptase polymerase chain reaction for the PML/RAR alpha fusion mRNA: a study in patients with acute promyelocytic leukemia following peripheral stem cell transplantation Leukemia 9(5): 889-892
Spiliotis, J.; Iavazzo, C.; Sugarbaker, P. 2021: Management of patients with advanced ovarian cancer - Role of complete cytoreduction and HIPEC: Attitudes of gynaecologist oncologists in two different continents Australian and New Zealand Journal of Obstetrics and Gynaecology 61(1): E1-E2
Nakajima, K.; Hisazumi, H.; Nakashima, T.; Yokoyama, O.; Nagano, K.; Kobashi, K.; Naito, K.; Misaki, T.; Saito, Y.; Takashima, T. 1987: A combined treatment of interferon-alpha, 8 MHz radiofrequency hyperthermia and/or irradiation in a patient with advanced renal cancer Hinyokika Kiyo. Acta Urologica Japonica 33(11): 1851-1856
Chao, T.Y.; Hwang, W.S.; Yang, M.J.; Chang, J.Y.; Wang, C.C.; Hseuh, E.J.; Huang, S.H.; Chen, W.C. 1995: Combination chemoimmunotherapy with interferon-alpha and cisplatin in patients with advanced non-small cell lung cancer Zhonghua Yi Xue Za Zhi 56(4): 232-238
Trandafir, L.; Ruffié, P.; Borel, C.; Monnet, I.; Soulié, P.; Adams, D.; Cvitkovic, E.; Armand, J.P. 1997: Higher doses of alpha-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesothelioma European Journal of Cancer 33(11): 1900-1902
Menczer, J.; Ben-Baruch, G.; Rizel, S.; Brenner, H. 1995: Intraperitoneal chemotherapy with cisplatin and etoposide in ovarian carcinoma patients who are clinically in complete remission European Journal of Gynaecological Oncology 16(1): 12-17
Gavrilova, I.E.; Kuznetsov, I.P.; Denisov, L.A.; Maiakova, S.A.; Orlova, T.G.; Kadagidze, Z.G.; Makhonova, L.A. 1991: Use of alpha interferon preparations in acute lymphoblastic leukemia in children during remission Pediatriia 11: 75-78
Cajozzo, A. 1990: Minimal residual disease in hematological neoplasms Recenti Progressi in Medicina 81(10): 655-657